Surgnova

Surgnova Focuses on Minimally Invasive Surgery and Tumor Interventional Therapy, Providing Comprehensive Solutions for Minimally Invasive Surgical Treatment Globally. It Has Established Three Platforms: Surgical Vision, Surgical Energy, and Tumor Interventional Therapy.Its product portfolio mainly includes: 2D Electronic Laparoscope, 3D Electronic Thoracoabdominal Endoscope, Insufflator, Ultrasonic Soft Tissue Cutting and Hemostasis Device, Ultrasonic High-Frequency Surgical Integrated Operation Device, Electric Linear Cutter Stapler, Nano Pulse Generator, Microwave Ablation System, and Radiofrequency Ablation System, covering equipment and instruments used throughout minimally invasive surgery procedures. Among these, multiple products have obtained CE certification as well as approval from NMPA and FDA. Its products and services have entered more than 60 countries and regions across Europe, America, Asia, and Africa.In terms of R&D, Surgnova has established a research center in Beijing with over 10 laboratories specializing in electronics, mechanics, optics, acoustics, robotics, animal tissue, reliability, and more. To date, it has applied for nearly 60 national invention patents in China and approximately 10 PCT international invention patents. In Cixi, Zhejiang Province, it operates a 10,000-square-meter intelligent high-end medical device production base that complies with Medical Device (MD) GMP standards.The core founding team possesses decades of experience and profound expertise in R&D, production, registration, marketing, and other fields from working with international medical giants.